Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?

被引:1
|
作者
Ma, Tianyi [1 ]
Yuan, Huawei [1 ]
Guo, Zhanfang [1 ]
机构
[1] Dalian Univ Technol, Cent Hosp, Dept Gastroenterol & Hepatol, Dalian, Peoples R China
关键词
D O I
10.1111/liv.16082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:3103 / 3104
页数:2
相关论文
共 50 条
  • [21] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [22] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [23] Cardiovascular Disease Risk Is Increased In Adolescents With Metabolic Dysfunction-associated Steatotic Liver Disease
    Short, Kevin R.
    Palle, Sirish K.
    Tryggestad, Jeanie B.
    Hellman, Diana A.
    Sciarrillo, Christina M.
    Emerson, Sam R.
    Friedman, Jacob E.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 680 - 680
  • [24] Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
    Del Barrio Azaceta, Maria
    Iruzubieta, Paula
    Aller De La Fuente, Rocio
    Maria Banales, Jesus
    Santos-Laso, Alvaro
    Calleja Panero, Jose Luis
    Ibanez, Luis
    Arias Loste, Maria Teresa
    Romero Gomez, Manuel
    Garcia-Monzon, Carmelo
    Gomez-Camarero, Judith
    Gines, Pere
    Morillas, Rosa M.
    Manuel Pericas, Juan
    Aspichueta, Patricia
    Martin-Mateos, Rosa
    Gallego-Duran, Rocio
    De La Torre Sanchez, Mercedes
    Escudero-Garcia, Desamparados
    Bernal Monterde, Vanesa
    Benlloch, Salvador
    Turnes, Juan
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2022, 77 : S157 - S157
  • [25] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [26] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [27] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [28] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
  • [29] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi, Yiwen
    Fan, Jiangao
    CHINESE MEDICAL JOURNAL, 2022, 135 (09) : 1009 - 1018
  • [30] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi Yiwen
    Fan Jiangao
    中华医学杂志英文版, 2022, 135 (09) : 1009 - 1018